Latest News
US personal spending growth decelerates in July
US personal spending growth slowed down in July, according to the Commerce Department, as shortages of motor vehicles offset a rise in outlays on in-person services.
Beijing looks to ban Chinese tech firms from foreign listings
China will look to continue its crackdown on its tech sector by way of a ban on firms with large amounts of sensitive consumer data from going public in the United States.
Yew Grove collects 99% of H1 rents
Real estate investment trust Yew Grove said on Friday that it had collected 99% of first-half rents.
Asia report: Markets mixed ahead of Jackson Hole outcome
Markets in Asia closed in a mixed state on Friday, as investors closed their wallets ahead of the outcome of the US Federal Reserve’s Jackson Hole summit later in the global day.
London close: Stocks edge up as Powell speech lifts markets
London stocks closed in the black on Friday, boosted late in the day by Federal Reserve Chair Jerome Powell’s speech at the virtual Jackson Hole symposium.
Apple eases rules around App Store ahead of Epic Games ruling
US tech giant Apple has eased back rules regarding its App Store as part of an effort to settle a lawsuit brought by developers in advance of a ruling in a separate case brought against it by the makers of the highly popular video game Fortnite.
US close: Stocks weaker as investors keep watch on Jackson Hole
Wall Street stocks were in the red at the closing bell Thursday, as the Federal Reserve's two-day summit in Wyoming kicked off.
Europe close: Stocks pop after Powell remarks on tapering
European stocks managed a positive finish on Friday, after Fed chair Jerome Powell said the US central bank was on track to begin tapering by the end of the year.
Weekly review
The FTSE 100 ended the week 60. 11 points higher, closing at 7,148. 01 on Friday.
Director dealings: RPS CEO ups stake
RPS Group revealed on Friday that chief executive John Douglas had acquired 100,000 ordinary shares in the London-listed professional services firm.
East Imperial secures new supply deals in NZ, Australia
Premium mixer manufacturer East Imperial announced a series of “significant” new supply agreements across Australia and New Zealand on Friday.
Broker tips: Volex, Hunting, Babcock
Analysts at Canaccord Genuity raised their target price on electronic connectors manufacturer Volex from 475. 0p to 500. 0p on Friday following the group's acquisition of Irvine Electronics.
Triple Point places £195m in loan notes
Triple Point Social Housing said on Friday that it has put in place £195m of long-dated, fixed-rate, interest-only sustainability-linked loan notes through a private placement with MetLife Investment Management clients and Barings, respectively.
US open: Stocks trade higher following Powell speech
Wall Street stocks opened higher on Friday as investors digested comments from Federal Reserve chairman Jerome Powell.
Fed on track to taper by end of the year, says Powell
Federal Reserve chair Jerome Powell signalled on Friday that the US central bank is on track to start tapering asset purchases later in the year if the economy continues to show progress.
FTSE 250 movers: Trustpilot gains; Moonpig in the red
London's FTSE 250 was 0. 2% higher in afternoon trade on Friday at 23,987. 61.
FTSE 100 movers: Miners rally; Just Eat slides
London’s FTSE 100 was up 0. 1% at 7,134. 46 in afternoon trade on Friday.
Week ahead: Non-farm payrolls in focus; Barratt, Melrose earnings due
The corporate and macroeconomic calendars will start to pick up again next week after the August lull, culminating in the US jobs report at the end of the week.
D4T4 appoints deputy CEO to board
Business software company D4T4 Solutions has appointed its deputy chief executive officer Bill Bruno to the board with immediate effect, it announced on Friday.
Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody
Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn’s disease.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.